business. In February 2021, Charles River announced it would acquire Cognate BioServices, Inc. for $875 million. In March 2021, Charles River announced the... 18 KB (1,584 words) - 23:06, 15 February 2024 |
Caladrius Biosciences Inc. (2019-08-07). "Caladrius Biosciences and Cognate BioServices Establish Manufacturing Agreement for Phase 3 Confirmatory Pivotal... 22 KB (1,371 words) - 08:27, 18 February 2024 |
organization Cognate Bioservices for services supporting manufacture of its products for clinical trials. Their relationship with Cognate began before... 9 KB (1,097 words) - 22:46, 8 January 2024 |